Amgen (Switzerland)
In research, Amgen (Switzerland) stands highest in Medicine (#10,413 of 17,978 worldwide) and Health Sciences (#13,318 of 20,462 worldwide), over all time.
- World rank, all time
- #23,419 of 42,892
- Rank in Switzerland
- #230 of 429
- Research works
- 273 ▼ 6% vs 2013–17
- Citations
- 4.2k 15.4 per fractional work
- Top-10% rate
- 16.7% record average 16.5%
- Open access
- 44% world 28%
What is Amgen (Switzerland) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #10,413 of 17,978 | 15.9% | 153 | |
| Health SciencesDomain | #13,318 of 20,462 | 16.0% | 159 |
Each strip is that field’s whole ranked pool, with the notch where Amgen (Switzerland) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 8.6×. Every wedge is a field page.
- Economics, Econometrics and Finance 8.6×
- Immunology and Microbiology 3.5×
- Business, Management and Accounting 2.5×
- Medicine 2.1×
- Pharmacology, Toxicology and Pharmaceutics 1.4×
- Mathematics 1.2×
- Biochemistry, Genetics and Molecular Biology 1.0×
- Physics and Astronomy 0.7×
- Neuroscience 0.7×
- Social Sciences 0.5×
- Decision Sciences 0.4×
- Earth and Planetary Sciences 0.3×
- Agricultural and Biological Sciences 0.3×
- Engineering 0.3×
- Chemistry 0.3×
- Health Professions 0.2×
- Computer Science 0.2×
- Environmental Science 0.2×
- Arts and Humanities 0.2×
- Materials Science 0.2×
Who are the top researchers at Amgen (Switzerland)?
Ranked on the composite score, Mickael Löthgren, Guillermo Villa and Guy Hechmati lead among researchers whose main affiliation is Amgen (Switzerland).
- 1 Mickael Löthgren Switzerland · #354,639 worldwide 80 citations · 23 works
- 2 Guillermo Villa Switzerland · #904,038 worldwide 19 citations · 23 works
- 3 Guy Hechmati Switzerland · #1,555,172 worldwide 12 citations · 15 works
- 4 Lucie Kutikova Switzerland · #1,566,907 worldwide 4 citations · 15 works
Which keywords describe research at Amgen (Switzerland)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Cardiovascular Disease Prevention, Genetic Variants, Targeted Therapy, Financial Stability, C-Reactive Protein, Statins and Cholesterol-lowering.
- Foreign Direct Investment
- Regulatory T Cells
- Cytokines
- Investment Strategies
- Financial Toxicity
- Ethical Guidelines
- Cardiovascular Disease
- Industrial Policy
- Generic Drugs
- Climate Finance
- COVID-19
- Treatment Guidelines
- ALK Inhibitors
- Sustainable Development
- Cost-effectiveness Analysis
- LDL Cholesterol
- Targeted Therapy
- Financial Stability
- Genetic Variants
- Cardiovascular Disease Prevention
- Clinical Trials
- Quality of Life
- C-Reactive Protein
- Statins
- Cholesterol-lowering
- Chemotherapy
- Health Utility Measures
- Genomic Profiling
- EGFR Mutations
- Investment
- Inflammation
- Drug Development Costs
- Green Bonds
- Atherosclerosis
- Cost of Care
- European Union
- State Aid
- Sovereign Wealth Funds
- Molecular Subtypes
- Bilateral Investment Treaties
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Clinical Trials6▲ 19×7 topics
- Cardiovascular Disease Prevention3▲ 76×2 topics
- Quality of Life3▲ 4.4×6 topics
- Genetic Variants3▲ 36×3 topics
- C-Reactive Protein3▲ 79×2 topics
- Financial Stability3▲ 29×2 topics
- Statins3▲ 79×2 topics
- Targeted Therapy3▲ 27×3 topics
- Cholesterol-lowering3▲ 129×1 topic
- LDL Cholesterol3▲ 168×1 topic
- Chemotherapy2▲ 7.5×7 topics
- Cost-effectiveness Analysis2▲ 61×1 topic
- Health Utility Measures2▲ 61×1 topic
- Sustainable Development2▲ 3.2×4 topics
- Genomic Profiling2▲ 45×2 topics
- ALK Inhibitors2▲ 69×1 topic
- EGFR Mutations2▲ 69×1 topic
- Treatment Guidelines2▲ 20×2 topics
- Investment2▲ 41×2 topics
- COVID-192▲ 2.5×2 topics
- Inflammation2▲ 1.73×8 topics
- Climate Finance2▲ 177×1 topic
- Drug Development Costs2▲ 126×1 topic
- Generic Drugs2▲ 126×1 topic
- Green Bonds2▲ 177×1 topic
- Industrial Policy2▲ 30×2 topics
- Atherosclerosis1▲ 10×3 topics
- Cardiovascular Disease1▲ 2.6×8 topics
- Cost of Care1▲ 94×1 topic
- Ethical Guidelines1▲ 54×2 topics
- European Union1▲ 13×1 topic
- Financial Toxicity1▲ 94×1 topic
- State Aid1▲ 528×1 topic
- Investment Strategies1▲ 177×1 topic
- Sovereign Wealth Funds1▲ 223×1 topic
- Cytokines1▲ 8.4×2 topics
- Molecular Subtypes1▲ 28×2 topics
- Regulatory T Cells1▲ 20×2 topics
- Bilateral Investment Treaties1▲ 117×1 topic
- Foreign Direct Investment1▲ 45×1 topic
Which research topics does Amgen (Switzerland) publish most on?
By volume in 2022–2025: Lipoproteins and Cardiovascular Health, Health Systems, Economic Evaluations, Quality of Life, Lung Cancer Treatments and Mutations and Sustainable Finance and Green Bonds.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lipoproteins and Cardiovascular Health Surgery 3 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 4 Sustainable Finance and Green Bonds Finance 2 works
- 5 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
- 6 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 7 EU Law and Policy Analysis Law 1 works
- 8 State Capitalism and Financial Governance Strategy and Management 1 works
- 9 International Arbitration and Investment Law Strategy and Management 1 works
- 10 Colorectal Cancer Treatments and Studies Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Amgen (Switzerland)'s research output changed?
Output in 2018–2022 was 6% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Zug
- Varian Medical Systems (Switzerland)
- Biogen (Switzerland)
- University of Teacher Education Zug
- AstraZeneca (Switzerland)
- RHI Magnesita (Switzerland)
- Johnson & Johnson (Switzerland)
- SHL Medical (Switzerland)
- Sucampo (Switzerland)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.